Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Nizatidine
Drug ID BADD_D01582
Description A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.
Indications and Usage For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB00585
KEGG ID D00440
MeSH ID D016567
PubChem ID 3033637
TTD Drug ID D0Q9DK
NDC Product Code 72643-018; 55111-310; 0591-3138; 0591-3137; 63187-249; 68462-425; 55111-011; 68462-426; 60846-301; 55111-311
UNII P41PML4GHR
Synonyms Nizatidine | N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine | LY-139037 | LY 139037 | LY139037 | Axid
Chemical Information
Molecular Formula C12H21N5O2S2
CAS Registry Number 76963-41-2
SMILES CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams17.15.02.001; 19.02.03.001---
Amblyopia06.02.01.001---
Anaemia01.03.02.001--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Anxiety19.06.02.002--
Asthenia08.01.01.001---
Back pain15.03.04.005--
Blood uric acid increased13.02.04.001---
Body temperature increased13.15.01.001---
Breast enlargement21.05.04.001---
Bronchospasm10.01.03.012; 22.03.01.004--
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Cough22.02.03.001--
Crying08.01.03.005; 12.02.11.001; 17.02.05.013; 19.04.02.002---
Depression19.15.01.001--
Dermatitis23.03.04.002---
Dermatitis exfoliative10.01.01.004; 23.03.07.001--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dry mouth07.06.01.002--
Dyspepsia07.01.02.001--
Eosinophilia01.02.04.001--
Feeling abnormal08.01.09.014---
Flatulence07.01.04.002--
Gastrointestinal disorder07.11.01.001---
Gastrointestinal pain07.01.05.005--
Gout14.09.01.001; 15.01.06.001---
The 1th Page    1 2 3    Next   Last    Total 3 Pages